Wikidata

(Q46298030)

English

Liposomal daunorubicin versus standard daunorubicin: long term follow-up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemia

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

title
Liposomal daunorubicin versus standard daunorubicin: long term follow-up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemia (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18950458
retrieved
21 December 2017
reference URL
http://europepmc.org/abstract/MED/18950458
author

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q46298030&oldid=2104045214"